2014-11-26 22:56:00 UTC

Gastroenterology Podcast November 2014: Comparing Fecal Immunochemical Tests and Colonoscopy in Familial Colorectal Cancer Screening

A study in the November issue of Gastroenterology shows results of a controlled randomized trial to compare the efficacy of repeated fecal immunochemical tests (FITs) and colonoscopy in detecting advanced neoplasia (advanced adenoma or colorectal cancer [CRC]) in family members of patients with CRC. Dr. Kuemmerle speaks with the first author of the study, Dr. Enrique Quintero of the University of La Laguna; Plus, a rundown of top stories from this month's issue of GI and Hepatology News.

 

 

Masclee Quintero E, Carrillo M, Gimeno-García AZ, et al. Equivalency of Fecal Immunochemical Tests and Colonoscopy in Familial Colorectal Cancer Screening. Gastroenterology 2014; November; 147(5): 1021–1030.e1
Abstract

 

 

Duration: 12.58m
Filetype: mp3
Bitrate: 96 KBPS
Frequency: 44100 HZ

More on Colorectal Cancer

Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting

Aug. 1, 2017

We analyzed data from a large healthcare system that replaced the gFOBT with the FIT to determine the effects on CRC screening.

Familial Risk and Heritability of Colorectal Cancer in the Nordic Twin Study of Cancer

Aug. 1, 2017

We analyzed data from twins to determine how much the familial risk of colorectal cancer can be attributed to genetic factors vs environment.

Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing

Aug. 1, 2017

We found that among persons screened by fecal immunochemical tests, 23% developed FIT interval cancer.